Roche NimbleGen Partners with CapitalBio to Prepare Arrays for Diagnostics
November 16, 2010
Roche NimbleGen Partners with CapitalBio to Prepare Arrays for Diagnostics
Roche NimbleGen will work with Beijing-based CapitalBio to develop instruments and products to enhance and automate its microarray workflow for use in preventive and personalized diagnostics.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CapitalBio, Ahead of Lab Expansion, Debuts Chromosomal Microarray Analysis Services in China
January 2, 2013 / BioArray News - After Decade as CRO, Shanghai Biochip Plans Move into Chinese Molecular Dx Market
December 18, 2012 / BioArray News - CapitalBio Deafness Test Being Evaluated for Neonatal Screening in Three Major Chinese Cities
November 13, 2012 / BioArray News - Chinese Regulators Clear Affymetrix Platform for Clinical Use
February 21, 2012 / BioArray News - Genetic Analysis, with New CEO at the Helm, Aims to Have IBS Test CE-IVD Marked This Year
February 26, 2013 / BioArray News